- Target
- CEP85
- Reactivity
- Human,Mouse
- Application
- WB
- MW(Calculated)
- --
- MW(Observed)
- 85kD
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human CEP85 AA range: 267-317
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of CEP85 at Human/Mouse
- Gene Name
- CEP85 CCDC21
- Protein Name
- CEP85
- Other Name
- Centrosomal protein of 85 kDa;Coiled-coil domain-containing protein 21;
- Organism-1
- Human
- Gene ID-1
- 64793
- SwissProt-1
- Q6P2H3
- Organism-2
- Mouse
- Gene ID-2
- 70012
- SwissProt-2
- Q8BMK0
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, spindle pole . Nucleus, nucleolus . Localizes to centrosomes and nucleolus in interphase. Upon entry into mitosis, relocates from nucleolus and accumulates at spindle poles (PubMed:21399614). Associated with the pericentriolar material. Localizes to centrosomes at a low level in G1 phase and a slightly increased level in S phase, with gradually elevated levels during G2 phase. The levels at centrosomes further increase at G2/M, reaching a peak at spindle poles at early mitotic stages and remain high until the end of anaphase (PubMed:26220856). .